{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T08:53:47Z","timestamp":1781859227128,"version":"3.54.5"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1007626","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:00:00Z","timestamp":1583280000000}}],"reference-count":89,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T00:00:00Z","timestamp":1582243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100001906","name":"Washington Research Foundation","doi-asserted-by":"publisher","award":["Postdoctoral Fellowship"],"award-info":[{"award-number":["Postdoctoral Fellowship"]}],"id":[{"id":"10.13039\/100001906","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI068635"],"award-info":[{"award-number":["AI068635"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007813","name":"Center for AIDS Research, University of Washington","doi-asserted-by":"publisher","award":["AI027757"],"award-info":[{"award-number":["AI027757"]}],"id":[{"id":"10.13039\/100007813","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1007626","type":"journal-article","created":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T18:59:51Z","timestamp":1582311591000},"page":"e1007626","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":30,"title":["Mathematical modeling to reveal breakthrough mechanisms in the HIV Antibody Mediated Prevention (AMP) trials"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5684-9538","authenticated-orcid":true,"given":"Daniel B.","family":"Reeves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunda","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth R.","family":"Duke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan T.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8690-9896","authenticated-orcid":true,"given":"E. Fabian","family":"Cardozo-Ojeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florencia A.","family":"Boshier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3295-0372","authenticated-orcid":true,"given":"David A.","family":"Swan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"Rolland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merlin L.","family":"Robb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5293-4695","authenticated-orcid":true,"given":"John R.","family":"Mascola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myron S.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2179-2436","authenticated-orcid":true,"given":"Lawrence","family":"Corey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter B.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2598-1621","authenticated-orcid":true,"given":"Joshua T.","family":"Schiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,2,21]]},"reference":[{"issue":"15","key":"pcbi.1007626.ref001","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1073\/pnas.1703236114","article-title":"Preventing acquisition of HIV is the only path to an AIDS-free generation","volume":"114","author":"L Corey","year":"2017","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"27","key":"pcbi.1007626.ref002","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men","volume":"363","author":"RM Grant","year":"2010","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"pcbi.1007626.ref003","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJMoa1108524","article-title":"Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women","volume":"367","author":"JM Baeten","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"pcbi.1007626.ref004","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1600693","article-title":"Antiretroviral Therapy for the Prevention of HIV-1 Transmission","volume":"375","author":"MS Cohen","year":"2016","journal-title":"New England Journal of Medicine"},{"key":"pcbi.1007626.ref005","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/imr.12511","article-title":"Use of broadly neutralizing antibodies for HIV-1 prevention","volume":"275","author":"A Pegu","year":"2017","journal-title":"Immunological Reviews"},{"issue":"3","key":"pcbi.1007626.ref006","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.chom.2016.02.002","article-title":"HIV-Host Interactions: Implications for Vaccine Design","volume":"19","author":"BF Haynes","year":"2016","journal-title":"Cell Host and Microbe"},{"issue":"319","key":"pcbi.1007626.ref007","doi-asserted-by":"crossref","first-page":"319ra206","DOI":"10.1126\/scitranslmed.aad5752","article-title":"Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection","volume":"7","author":"RM Lynch","year":"2015","journal-title":"Science Translational Medicine"},{"issue":"7557","key":"pcbi.1007626.ref008","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nature14411","article-title":"Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117","volume":"522","author":"M Caskey","year":"2015","journal-title":"Nature"},{"issue":"6288","key":"pcbi.1007626.ref009","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1126\/science.aaf1279","article-title":"Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo","volume":"352","author":"CL Lu","year":"2016","journal-title":"Science"},{"key":"pcbi.1007626.ref010","first-page":"NEJMoa1608243","article-title":"Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption","author":"KJ Bar","year":"2016","journal-title":"New England Journal of Medicine"},{"issue":"7613","key":"pcbi.1007626.ref011","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nature18929","article-title":"HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption","volume":"535","author":"JF Scheid","year":"2016","journal-title":"Nature"},{"issue":"8","key":"pcbi.1007626.ref012","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/nm.1974","article-title":"Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques","volume":"15","author":"AJ Hessell","year":"2009","journal-title":"Nature Medicine"},{"issue":"6303","key":"pcbi.1007626.ref013","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1126\/science.aag0491","article-title":"Antibody-mediated protection against SHIV challenge includes systemic clearance of distal virus","volume":"353","author":"J Liu","year":"2016","journal-title":"Science (New York, NY)"},{"issue":"7601","key":"pcbi.1007626.ref014","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature17677","article-title":"A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges","volume":"533","author":"R Gautam","year":"2016","journal-title":"Nature"},{"issue":"4","key":"pcbi.1007626.ref015","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nm.4063","article-title":"Early short-term treatment with neutralizing human monoclonal antibodies halts SHIV infection in infant macaques","volume":"22","author":"AJ Hessell","year":"2016","journal-title":"Nature Medicine"},{"issue":"7646","key":"pcbi.1007626.ref016","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature21435","article-title":"Early antibody therapy can induce long-lasting immunity to SHIV","volume":"543","author":"Y Nishimura","year":"2017","journal-title":"Nature"},{"issue":"1","key":"pcbi.1007626.ref017","doi-asserted-by":"crossref","DOI":"10.1515\/scid-2016-0001","article-title":"Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials","volume":"9","author":"PB Gilbert","year":"2017","journal-title":"Statistical Communications in Infectious Diseases"},{"issue":"5993","key":"pcbi.1007626.ref018","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.1187659","article-title":"Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1","volume":"329","author":"X Wu","year":"2010","journal-title":"Science"},{"issue":"0","key":"pcbi.1007626.ref019","first-page":"1","article-title":"Modeling cumulative overall prevention efficacy for the VRC01 phase 2b efficacy trials","volume":"0","author":"Y Huang","year":"2018","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"3","key":"pcbi.1007626.ref020","doi-asserted-by":"crossref","first-page":"e1006860","DOI":"10.1371\/journal.ppat.1006860","article-title":"Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infections","volume":"14","author":"K Wagh","year":"2018","journal-title":"PLoS Pathogens"},{"issue":"324","key":"pcbi.1007626.ref021","doi-asserted-by":"crossref","first-page":"324ra15","DOI":"10.1126\/scitranslmed.aad6654","article-title":"Mathematical modeling of herpes simplex virus-2 suppression with pritelivir predicts trial outcomes","volume":"8","author":"JT Schiffer","year":"2016","journal-title":"Science Translational Medicine"},{"issue":"13","key":"pcbi.1007626.ref022","doi-asserted-by":"crossref","first-page":"e00095","DOI":"10.1128\/JVI.00095-17","article-title":"Autologous Stem Cell Transplantation Disrupts Adaptive Immune Responses during Rebound Simian\/Human Immunodeficiency Virus Viremia","volume":"91","author":"DB Reeves","year":"2017","journal-title":"Journal of Virology"},{"key":"pcbi.1007626.ref023","first-page":"NEJMoa1508952","article-title":"Prospective Study of Acute HIV-1 Infection in Adults in East Africa and Thailand","author":"ML Robb","year":"2016","journal-title":"New England Journal of Medicine"},{"issue":"0","key":"pcbi.1007626.ref024","first-page":"1","article-title":"Population pharmacokinetics analysis of VRC01, an HIV-1 broadly neutralizing monoclonal antibody, in healthy adults","volume":"0","author":"Y Huang","year":"2017","journal-title":"mAbs"},{"issue":"W1","key":"pcbi.1007626.ref025","doi-asserted-by":"crossref","first-page":"W213","DOI":"10.1093\/nar\/gkv404","article-title":"CATNAP: A tool to compile, analyze and tally neutralizing antibody panels","volume":"43","author":"H Yoon","year":"2015","journal-title":"Nucleic Acids Research"},{"issue":"46","key":"pcbi.1007626.ref026","doi-asserted-by":"crossref","first-page":"18921","DOI":"10.1073\/pnas.1214785109","article-title":"Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo","volume":"109","author":"B Moldt","year":"2012","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"10","key":"pcbi.1007626.ref027","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.tim.2014.08.006","article-title":"In vivo protection by broadly neutralizing HIV antibodies","volume":"22","author":"MJ van Gils","year":"2014","journal-title":"Trends in Microbiology"},{"issue":"3","key":"pcbi.1007626.ref028","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.chom.2019.08.014","article-title":"A Meta-analysis of Passive Immunization Studies Shows that Serum-Neutralizing Antibody Titer Associates with Protection against SHIV Challenge","volume":"26","author":"A Pegu","year":"2019","journal-title":"Cell Host Microbe"},{"issue":"5","key":"pcbi.1007626.ref029","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1128\/JVI.03136-14","article-title":"Improving Neutralization Potency and Breadth by Combining Broadly Reactive HIV-1 Antibodies Targeting Major Neutralization Epitopes","volume":"89","author":"R Kong","year":"2015","journal-title":"Journal of Virology"},{"issue":"3","key":"pcbi.1007626.ref030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1005520","article-title":"Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C Infection","volume":"12","author":"K Wagh","year":"2016","journal-title":"PLoS Pathogens"},{"key":"pcbi.1007626.ref031","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1098\/rsif.2005.0042","article-title":"Perspectives on the basic reproductive ratio","volume":"2","author":"JM Heffernan","year":"2005","journal-title":"Journal of The Royal Society Interface"},{"issue":"12","key":"pcbi.1007626.ref032","doi-asserted-by":"crossref","first-page":"6096","DOI":"10.1128\/JVI.00127-10","article-title":"Estimation of the initial viral growth rate and basic reproductive number during acute HIV-1 infection","volume":"84","author":"RM Ribeiro","year":"2010","journal-title":"Journal of virology"},{"issue":"6884","key":"pcbi.1007626.ref033","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/417095a","article-title":"HIV preferentially infects HIV-specific CD4+ T cells","volume":"417","author":"DC Douek","year":"2002","journal-title":"Nature"},{"issue":"3","key":"pcbi.1007626.ref034","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nm1380","article-title":"Pathogenesis of HIV infection: what the virus spares is as important as what it destroys","volume":"12","author":"Z Grossman","year":"2006","journal-title":"Nature Medicine"},{"issue":"3","key":"pcbi.1007626.ref035","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2013.09.020","article-title":"Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure","volume":"155","author":"YC Ho","year":"2013","journal-title":"Cell"},{"issue":"9","key":"pcbi.1007626.ref036","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nm.4156","article-title":"Defective proviruses rapidly accumulate during acute HIV-1 infection","volume":"22","author":"KM Bruner","year":"2016","journal-title":"Nature Medicine"},{"issue":"6","key":"pcbi.1007626.ref037","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1084\/jem.20090365","article-title":"The first T cell response to transmitted\/founder virus contributes to the control of acute viremia in HIV-1 infection","volume":"206","author":"N Goonetilleke","year":"2009","journal-title":"The Journal of Experimental Medicine"},{"issue":"1","key":"pcbi.1007626.ref038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2015.07.009","article-title":"What do mathematical models tell us about killing rates during HIV-1 infection?","volume":"168","author":"S Gadhamsetty","year":"2015","journal-title":"Immunology Letters"},{"issue":"8","key":"pcbi.1007626.ref039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1005805","article-title":"Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV Infection","volume":"12","author":"KR Demers","year":"2016","journal-title":"PLoS Pathogens"},{"issue":"3","key":"pcbi.1007626.ref040","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/cei.12692","article-title":"Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults","volume":"182","author":"JE Ledgerwood","year":"2015","journal-title":"Clinical and Experimental Immunology"},{"issue":"11","key":"pcbi.1007626.ref041","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/nrmicro3351","article-title":"A mechanistic theory to explain the efficacy of antiretroviral therapy","volume":"12","author":"SB Laskey","year":"2014","journal-title":"Nature Reviews Microbiology"},{"key":"pcbi.1007626.ref042","doi-asserted-by":"crossref","first-page":"8443","DOI":"10.1038\/ncomms9443","article-title":"Dose-response curve slope helps predict therapeutic potency and breadth of HIV broadly neutralizing antibodies","volume":"6","author":"NE Webb","year":"2015","journal-title":"Nature communications"},{"issue":"5","key":"pcbi.1007626.ref043","doi-asserted-by":"crossref","first-page":"e1006313","DOI":"10.1371\/journal.ppat.1006313","article-title":"Predicting HIV-1 transmission and antibody neutralization efficacy in vivo from stoichiometric parameters","volume":"13","author":"OF Brandenberg","year":"2017","journal-title":"PLoS Pathogens"},{"issue":"1","key":"pcbi.1007626.ref044","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1742-4690-10-56","article-title":"A novel acute HIV infection staging system based on 4th generation immunoassay","volume":"10","author":"J Ananworanich","year":"2013","journal-title":"Retrovirology"},{"issue":"S2","key":"pcbi.1007626.ref045","doi-asserted-by":"crossref","first-page":"S270","DOI":"10.1086\/655651","article-title":"The Detection of Acute HIV Infection","volume":"202","author":"M Cohen","year":"2010","journal-title":"The Journal of Infectious Diseases"},{"key":"pcbi.1007626.ref046","first-page":"jem.20190446-15","article-title":"Anti-idiotypic antibodies elicit anti-HIV-1-specific B cell responses","author":"P Dosenovic","year":"2019","journal-title":"The Journal of Experimental Medicine"},{"issue":"11","key":"pcbi.1007626.ref047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pmed.1002435","article-title":"Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial","volume":"14","author":"KH Mayer","year":"2017","journal-title":"PLoS Medicine"},{"key":"pcbi.1007626.ref048","doi-asserted-by":"crossref","first-page":"513","DOI":"10.7554\/eLife.31805","article-title":"A single, continuous metric to define tiered serum neutralization potency against HIV","volume":"7","author":"P Hraber","year":"2018","journal-title":"eLife"},{"issue":"19","key":"pcbi.1007626.ref049","doi-asserted-by":"crossref","first-page":"10406","DOI":"10.1128\/JVI.01155-10","article-title":"Low-Dose Mucosal Simian Immunodeficiency Virus Infection Restricts Early Replication Kinetics and Transmitted Virus Variants in Rhesus Monkeys","volume":"84","author":"J Liu","year":"2010","journal-title":"Journal of Virology"},{"issue":"5","key":"pcbi.1007626.ref050","first-page":"1","article-title":"High multiplicity infection by HIV-1 in men who have sex with men","volume":"6","author":"H Li","year":"2010","journal-title":"PLoS Pathogens"},{"issue":"8","key":"pcbi.1007626.ref051","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1005110","article-title":"Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal Antibodies","volume":"11","author":"LE McCoy","year":"2015","journal-title":"PLoS Pathogens"},{"issue":"20","key":"pcbi.1007626.ref052","doi-asserted-by":"crossref","first-page":"e01187","DOI":"10.1128\/JVI.01187-17","article-title":"Protective Efficacy of Broadly Neutralizing Antibodies with Incomplete Neutralization Activity against Simian-Human Immunodeficiency Virus in Rhesus Monkeys","volume":"91","author":"B Julg","year":"2017","journal-title":"Journal of Virology"},{"key":"pcbi.1007626.ref053","doi-asserted-by":"crossref","DOI":"10.1093\/acprof:oso\/9780199773596.001.0001","volume-title":"Analysis of multiple dependent variables","author":"P Dattalo","year":"2013"},{"issue":"7","key":"pcbi.1007626.ref054","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nm0703-847","article-title":"Transmission, acute HIV-1 infection and the quest for strategies to prevent infection","volume":"9","author":"M Pope","year":"2003","journal-title":"Nature Medicine"},{"issue":"6","key":"pcbi.1007626.ref055","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nri2302","article-title":"Setting the stage: host invasion by HIV","volume":"8","author":"F Hladik","year":"2008","journal-title":"Nature Reviews Immunology"},{"issue":"20","key":"pcbi.1007626.ref056","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1056\/NEJMra1011874","article-title":"Acute HIV-1 Infection","volume":"364","author":"MS Cohen","year":"2011","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"pcbi.1007626.ref057","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1741-7007-11-96","article-title":"Modeling the within-host dynamics of HIV infection","volume":"11","author":"AS Perelson","year":"2013","journal-title":"BMC Biology"},{"issue":"2","key":"pcbi.1007626.ref058","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1137\/120876800","article-title":"Stochastic Analysis of Pre- and Postexposure Prophylaxis against HIV Infection","volume":"73","author":"JM Conway","year":"2013","journal-title":"SIAM Journal on Applied Mathematics"},{"key":"pcbi.1007626.ref059","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.epidem.2017.03.002","article-title":"On the duration of the period between exposure to HIV and detectable infection","volume":"20","author":"BP Konrad","year":"2017","journal-title":"Epidemics"},{"key":"pcbi.1007626.ref060","doi-asserted-by":"crossref","first-page":"e1006740","DOI":"10.1371\/journal.pcbi.1006740","article-title":"Mechanistic framework predicts drug-class specific utility of antiretrovirals for HIV prophylaxis","volume":"15","author":"S Duwal","year":"2019","journal-title":"PLoS Computational Biology"},{"issue":"14","key":"pcbi.1007626.ref061","doi-asserted-by":"crossref","first-page":"9217","DOI":"10.1128\/JVI.79.14.9217-9227.2005","article-title":"Propagation and Dissemination of Infection after Vaginal Transmission of Simian Immunodeficiency Virus","volume":"79","author":"CJ Miller","year":"2005","journal-title":"Journal of Virology"},{"issue":"2","key":"pcbi.1007626.ref062","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S1473-3099(09)70021-0","article-title":"Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies","volume":"9","author":"MC Boily","year":"2009","journal-title":"The Lancet Infectious Diseases"},{"issue":"8","key":"pcbi.1007626.ref063","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1128\/JVI.03608-14","article-title":"HIV-1 fitness cost associated with escape from the VRC01 class of CD4 binding site neutralizing antibodies","volume":"89","author":"RM Lynch","year":"2015","journal-title":"Journal of virology"},{"issue":"14","key":"pcbi.1007626.ref064","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","article-title":"Immune-correlates analysis of an HIV-1 vaccine efficacy trial","volume":"366","author":"BF Haynes","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"10","key":"pcbi.1007626.ref065","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/nm.3932","article-title":"HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders","volume":"21","author":"H Janes","year":"2015","journal-title":"Nature Medicine"},{"issue":"5034","key":"pcbi.1007626.ref066","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1126\/science.1683006","article-title":"Antigenic diversity thresholds and the development of AIDS","volume":"254","author":"MA Nowak","year":"1991","journal-title":"Science"},{"issue":"1","key":"pcbi.1007626.ref067","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0025-5564(93)90043-A","article-title":"Dynamics of HIV infection of CD4+ T cells","volume":"114","author":"AS Perelson","year":"1993","journal-title":"Mathematical Biosciences"},{"issue":"13","key":"pcbi.1007626.ref068","doi-asserted-by":"crossref","first-page":"6971","DOI":"10.1073\/pnas.94.13.6971","article-title":"Virus dynamics and drug therapy","volume":"94","author":"S Bonhoeffer","year":"1997","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5","key":"pcbi.1007626.ref069","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.cell.2010.11.001","article-title":"Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue","volume":"143","author":"G Doitsh","year":"2010","journal-title":"Cell"},{"issue":"6","key":"pcbi.1007626.ref070","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1128\/JVI.03428-13","article-title":"The majority of CD4+ T-cell depletion during acute simian-human immunodeficiency virus SHIV89.6P infection occurs in uninfected cells","volume":"88","author":"L Matrajt","year":"2014","journal-title":"Journal of virology"},{"issue":"1","key":"pcbi.1007626.ref071","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1038\/s41598-017-04160-3","article-title":"Anti-proliferative therapy for HIV cure: a compound interest approach","volume":"7","author":"DB Reeves","year":"2017","journal-title":"Scientific Reports"},{"issue":"3","key":"pcbi.1007626.ref072","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1006\/jtbi.1997.0548","article-title":"Target cell limited and immune control models of HIV infection: a comparison","volume":"190","author":"RJ De Boer","year":"1998","journal-title":"Journal of theoretical biology"},{"issue":"1","key":"pcbi.1007626.ref073","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1600-065X.2006.00485.x","article-title":"Understanding the mechanisms and limitations of immune control of HIV","volume":"216","author":"MP Davenport","year":"2007","journal-title":"Immunological Reviews"},{"issue":"5","key":"pcbi.1007626.ref074","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1084\/jem.20001021","article-title":"Estimating the precursor frequency of naive antigen-specific CD8 T cells","volume":"195","author":"JN Blattman","year":"2002","journal-title":"The Journal of experimental medicine"},{"issue":"7","key":"pcbi.1007626.ref075","article-title":"HIV model parameter estimates from interruption trial data including drug efficacy and reservoir dynamics","volume":"7","author":"R Luo","year":"2012","journal-title":"PLoS ONE"},{"issue":"8","key":"pcbi.1007626.ref076","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.1128\/JVI.77.8.5037-5038.2003","article-title":"A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo","volume":"77","author":"M Markowitz","year":"2003","journal-title":"Journal of virology"},{"issue":"48","key":"pcbi.1007626.ref077","doi-asserted-by":"crossref","first-page":"19079","DOI":"10.1073\/pnas.0707449104","article-title":"Determination of virus burst size in vivo using a single-cycle SIV in rhesus macaques","volume":"104","author":"HY Chen","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"9192","key":"pcbi.1007626.ref078","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/S0140-6736(99)02035-8","article-title":"Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis","volume":"354","author":"B Ramratnam","year":"1999","journal-title":"Lancet"},{"issue":"1","key":"pcbi.1007626.ref079","doi-asserted-by":"crossref","first-page":"e1004677","DOI":"10.1371\/journal.pcbi.1004677","article-title":"Residual Viremia in Treated HIV+ Individuals","volume":"12","author":"JM Conway","year":"2016","journal-title":"PLoS computational biology"},{"issue":"6","key":"pcbi.1007626.ref080","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nm880","article-title":"Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells","volume":"9","author":"JD Siliciano","year":"2003","journal-title":"Nature medicine"},{"key":"pcbi.1007626.ref081","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1084\/jem.194.9.1277","article-title":"Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy","volume":"194","author":"H Mohri","year":"2001","journal-title":"Journal of Experimental Medicine"},{"issue":"2","key":"pcbi.1007626.ref082","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.immuni.2016.01.010","article-title":"In Vivo Killing Capacity of Cytotoxic T Cells Is Limited and Involves Dynamic Interactions and T Cell Cooperativity","volume":"44","author":"S Halle","year":"2016","journal-title":"Immunity"},{"issue":"2","key":"pcbi.1007626.ref083","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1074-7613(00)80470-7","article-title":"Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection","volume":"8","author":"K Murali-Krishna","year":"1998","journal-title":"Immunity"},{"issue":"2","key":"pcbi.1007626.ref084","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1001058","article-title":"Stochastic theory of early viral infection: Continuous versus burst production of virions","volume":"7","author":"JE Pearson","year":"2011","journal-title":"PLoS Computational Biology"},{"issue":"4","key":"pcbi.1007626.ref085","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1063\/1.1378322","article-title":"Approximate accelerated stochastic simulation of chemically reacting systems","volume":"115","author":"DT Gillespie","year":"2001","journal-title":"The Journal of Chemical Physics"},{"issue":"12","key":"pcbi.1007626.ref086","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.it.2007.08.009","article-title":"Do most lymphocytes in humans really reside in the gut?","volume":"28","author":"VV Ganusov","year":"2007","journal-title":"Trends in Immunology"},{"issue":"7419","key":"pcbi.1007626.ref087","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nature11398","article-title":"HIV-infected T cells are migratory vehicles for viral dissemination","volume":"490","author":"TT Murooka","year":"2012","journal-title":"Nature"},{"issue":"3","key":"pcbi.1007626.ref088","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/infdis\/jir747","article-title":"Determinants of Per-Coital-Act HIV-1 Infectivity Among African HIV-1\u2013Serodiscordant Couples","volume":"205","author":"JP Hughes","year":"2012","journal-title":"The Journal of Infectious Diseases"},{"issue":"6","key":"pcbi.1007626.ref089","doi-asserted-by":"crossref","first-page":"e329","DOI":"10.1016\/S2352-3018(18)30045-6","article-title":"The averted infections ratio: a novel measure of effectiveness of experimental HIV pre-exposure prophylaxis agents","volume":"5","author":"DT Dunn","year":"2018","journal-title":"The Lancet HIV"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1007626","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:00:00Z","timestamp":1583280000000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1007626","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T19:48:09Z","timestamp":1583351289000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1007626"}},"subtitle":[],"editor":[{"given":"James","family":"Gallo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,2,21]]},"references-count":89,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1007626","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pcbi.1007626","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,21]]}}}